0001415889-22-007599.txt : 20220708
0001415889-22-007599.hdr.sgml : 20220708
20220708171852
ACCESSION NUMBER: 0001415889-22-007599
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220706
FILED AS OF DATE: 20220708
DATE AS OF CHANGE: 20220708
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kummeth Charles R.
CENTRAL INDEX KEY: 0001534980
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 221075302
MAIL ADDRESS:
STREET 1: 425 MARTINGALE ROAD
STREET 2: SUITE 1000
CITY: SCHAUMBURG
STATE: IL
ZIP: 60173-2213
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
form4-07082022_020741.xml
X0306
4
2022-07-06
0000842023
BIO-TECHNE Corp
TECH
0001534980
Kummeth Charles R.
614 MCKINLEY PL N E
MINNEAPOLIS
MN
55413
true
true
false
false
CHIEF EXECUTIVE OFFICER
Common Stock
2022-07-06
4
M
0
50000
108.49
A
248338
D
Common Stock
2022-07-06
4
F
0
30935
362.78
D
217403
D
Common Stock
100
I
By Step-Son
Common Stock
100
I
By Step-Daughter
Stock Option (right to buy)
108.49
2022-07-06
4
M
0
50000
0
D
2022-08-07
Common Stock
50000
45346
D
Stock Options (right to buy)
106.59
2023-08-18
Common Stock
256010
256010
D
Stock Options (right to buy)
125.05
2024-08-09
Common Stock
194771
194771
D
Stock Options (right to buy)
177.32
2025-08-08
Common Stock
90334
90334
D
Stock Options (right to buy)
177.32
2025-08-08
Common Stock
60222
60222
D
Restricted Stock Units
Common Stock
16937
16937
D
Stock Options (right to buy)
190.41
2026-08-07
Common Stock
85725
85725
D
Stock Options (right to buy)
190.41
2026-08-07
Common Stock
57150
57150
D
Restricted Stock Units
Common Stock
12879
12879
D
Stock Options (right to buy)
267.87
2027-08-05
Common Stock
57442
57442
D
Stock Options (right to buy)
267.87
2027-08-05
Common Stock
38295
38295
D
Stock Options (right to buy)
267.87
2027-08-05
Common Stock
16650
16650
D
Stock Options (right to buy)
267.87
2027-08-05
Common Stock
16650
16650
D
Restricted Stock Units
Common Stock
8016
8016
D
Stock Options (right to buy)
481.82
2028-08-06
Common Stock
31315
31315
D
Stock Options (right to buy)
481.82
2028-08-06
Common Sstock
20876
20876
D
Includes (i) 3,763 shares of restricted stock for which the risk of forfeiture will lapse on August 7, 2022; (ii) 5,724 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2022 and August 5, 2023; and (iii) 5,344 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on August 6, 2022 and as to 1,781 shares on each of August 6, 2023 and August 6, 2024.
Fully exercisable.
Options to purchase 15,056 shares vests on each of 8/8/2019 and 8/8/2020 and options to purchase 15,055 shares vests on each of 8/8/2021 and 8/8/2022.
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 14,288 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 14,287 shares vest on each of 8/7/2022 and 6/7/2023.
Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later ate as performance is certified by the Administrator).
Options to purchase 9,573 shares vest on 8/5/21 and options to purchase 9,574 shares vest on each of 8/5/22, 8/5/23 and 8/5/24.
Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
Options to purchase 5,550 shares vest on each of 8/5/21, 8/5/22 and 8/5/23.
Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 5,219 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
/s/ Brenda S. Furlow, Attorney-in-Fact
2022-06-09